Publication | Open Access
ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy
94
Citations
30
References
2016
Year
Longitudinal gene-panel ctDNA sequencing could be exploited to determine resistance and guide the precise administration of anti-HER2 targeted therapy in the metastatic setting.
| Year | Citations | |
|---|---|---|
Page 1
Page 1